Show of support for Cell Therapeutics
A huge trade is betting that Cell Therapeutics will not become a penny stock.
More than 20,000 CTIC options have change hands already today, compared to a full-session average of 1,100 contracts in the last month. Virtually all of that volume is in one trade.
optionMONSTER systems detected the sale of 20,000 June 1 puts for $0.06 this morning. The volume was twice the previous open interest in the strike, clearly showing that this is a new position.
The put seller apparently believes that the cancer-drug developer will continue holding above $1 in coming months. He or she is also willing to buy shares if they fall below that strike price. Such "nickel" strategies have a high probability of profit but also high risk, as they are usually leveraged up to get a reasonable profit. (See our Education section)
CTIC is up fractionally at $1.17 today. It has tested support at $1 in the last few weeks but hasn't traded below that key level since gapping higher at the start of September.
More From optionMONSTER
